Assignee
BIOVEC LLC
US·9 granted patents·75 citations·filing 2003–2011
Top patents by PatentIndex Score
9 records- 0194US7481998B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2007·Granted Jan 27, 2009·14 cites·9 claims
- 0293US7501114B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2007·Granted Mar 10, 2009·22 cites·20 claims
- 0390US7179459B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2003·Granted Feb 20, 2007·21 cites·14 claims
- 0489US7687058B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2008·Granted Mar 30, 2010·7 cites·18 claims
- 0588US7670597B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2006·Granted Mar 2, 2010·7 cites·12 claims
- 0684US7803365B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2007·Granted Sep 28, 2010·4 cites·14 claims
- 0767US7713522B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2008·Granted May 11, 2010·0 cites·11 claims
- 0859US8367056B2In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectorsBIOVEC LLC·Filed 2011·Granted Feb 5, 2013·0 cites·8 claims
- 0958US8048410B2In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectorsBIOVEC LLC·Filed 2010·Granted Nov 1, 2011·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when BIOVEC LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →